These results suggest that MG patients presenting with severe symptoms or rapid disease progression at admission necessitate comprehensive Titin-Ab testing, enhanced screening for thyroid dysfunction, and close monitoring for respiratory muscle involvement. The gene discussed is TTN; the disease is myasthenia gravis.